NasdaqGS - Delayed Quote USD

Y-mAbs Therapeutics, Inc. (YMAB)

Compare
14.45 +0.25 (+1.76%)
At close: October 18 at 4:00 PM EDT
14.45 0.00 (0.00%)
After hours: October 18 at 4:20 PM EDT

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

27.6

Medium

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
KYMR Kymera Therapeutics, Inc. 28 -- -- --
PTGX Protagonist Therapeutics, Inc. 28 -- -- --
YMAB Y-mAbs Therapeutics, Inc. 28 -- -- --
CORT Corcept Therapeutics Incorporat 28 -- -- --
BTAI BioXcel Therapeutics, Inc. 28 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
YMAB
Category Average
1 Low Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers